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By: Irene Papanicolas and Jonathan Cylus
Summary: Many comparative efficiency metrics focus on scrutinising 
the operation of specific parts of a single health system. This article 
reviews the key issues involved in international comparisons of various 
aspects of efficiency. It examines data sources and analytic techniques 
used to create comparative indicators, and discusses approaches to 
interpreting variations. It also highlights key challenges and promising 
new initiatives, such as the consistent use of international definitions 
and technical developments, such as data linkages, which hold the 
potential to enhance work in this area.
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Introduction
As spending, demographic and 
technological pressures on health care 
continue to rise across health systems, 
the resources to meet these challenges 
are limited. This issue has produced a 
drive for policy-makers to identify and 
correct for inefficiencies in every aspect 
of health care – its delivery to patients, 
its technology, its business models and 
its policies. To monitor and pinpoint the 
causes of variability, it can be helpful 
to compare efficiency within, as well 
as across countries. Looking abroad, to 
comparative data on health systems which 
are designed differently, can be useful 
both for benchmarking as well as to try 
to gauge whether different types of health 
care delivery or policies may be successful 
at realising efficiency gains or improving 
health. As a result, for some time many 
policy-makers and researchers have been 
interested in developing metrics that are 
able to compare health system efficiency 
across countries. 1   2   3  However, despite the 
interest surrounding them, internationally 
comparable efficiency indicators are 
among the most elusive of health system 
comparative performance metrics; with 
a 2008 review noting that of all health care 
efficiency studies, only 4% were cross-
country analyses. 4 
In this article we consider the availability 
of internationally comparative health 
system efficiency data, focusing primarily 
on measures of technical efficiency – i.e. 
the effectiveness of a given set of inputs 
to produce a given set of outputs or 
outcomes. 5 
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Types of efficiency data
We have already noted our interest in 
indicators that relate to a given set of 
inputs to produce a given set of outputs or 
outcomes. We do not consider allocative 
efficiency or dynamic efficiency as 
very few studies and datasets exist that 
collect or compare data on these types 
of efficiency across countries.
While our cross-country review includes 
both indicators that relate health system 
inputs (including but not limited to 
expenditures, personnel and beds) to 
a given set of health system outputs 
(including but not limited to physician 
visits and discharges), or health outcomes, 
we note that the distinction between health 
outcome-based and health care output-
based indicators is important. Outcome-
based approaches tend to be more policy 
relevant, given that what matters to 
patients and policy-makers is to obtain 
quality health services that will improve 
their health; however in practice, output-
based indicators are easier to collect and 
more widely available and thus more 
commonly used.
Cross-country databases
There are few longitudinal, regularly 
updated databases that compare health 
system efficiency across countries. Key 
resources of comparable cross-country 
data are collected and regularly updated 
by intergovernmental organisations, 
such as the World Health Organization 
(WHO), Eurostat, and the Organisation for 
Economic Cooperation and Development 
(OECD). Member countries typically 
supply these organisations with their own 
national data, which are then reviewed 
and harmonised to ensure comparability 
across countries and time (OECD/WHO/
Eurostat). Some resources such as the 
System of Health Accounts (SHA), for 
example, have made important advances 
on the input side to ensure that health care 
expenditure data are collected under a 
common framework and are comparable 
across countries.
Each of these databases is updated 
annually and covers a wide range of health 
care inputs (e.g. health care expenditure, 
physician density or hospital beds), outputs 
(e.g. hospital discharges) and outcomes 
(e.g. life expectancy or infant mortality) 
that can be used to compute efficiency 
metrics. In some cases, such as the OECD 
health data, the database contains only 
a few indicators that capture ratios of 
outputs and inputs, and which might allow 
efficiency comparison, such as average 
length of hospital stay or curative care 
occupancy rates.
‘‘policymakersneedtoconsidertheassumptionsbeingmade
While such indicators are often used to 
make direct efficiency comparisons across 
countries, they should be used with caution 
as the data will also include information 
on both potential inefficiencies, as well as 
differences reflecting case-mix of patients 
across countries, as well organisational 
differences reflecting different treatment 
patterns or settings (for example, 
definitions of an acute care bed differ 
across countries). As the data are not 
adjusted for these confounding factors, 
one would not be able to make an informed 
statement of whether differences in length-
of-stay are due to more efficient practices 
or other factors. The case-mix issue can 
be partially accounted for by focusing on 
the length-of-stay for specific diagnostic 
categories, though this still cannot adjust 
for variations in case-severity within a 
diagnostic category.
Occasionally, some expenditure-based 
data, such as total health spending as 
a share of GDP, are used to compare 
efficiency across countries. These too 
should be interpreted with caution as 
they assume that health outcomes are 
identical across countries, so that using 
fewer resources implies greater efficiency. 
Despite the existence of few comparable 
efficiency metrics in most international 
databases, the large number of input 
and output/outcome information allows 
researchers and policy-makers to manually 
calculate simple efficiency indicators, such 
as metrics that relate health expenditure 
data to health outcome data, such as life 
expectancy or amenable mortality rates. 
Some studies even relate such ratios 
to manually constructed production 
possibilities frontiers*, to better assess 
efficiency. 6 
While these measures can illustrate 
variations across countries, policy-
makers and researchers need to consider 
the assumptions being made when 
constructing such ratio measures, to 
best inform their correct interpretation. 
Outcomes such as life expectancy or 
avoidable mortality will be influenced by 
a host of factors outside of the health care 
system, making it difficult to conclusively 
attribute these ratios to differences in 
health system efficiency. While better 
quality data on health care quality and 
health outcomes is becoming available 
(through datasets such as the OECD 
Health Care Quality Indicators Project), it 
is still a challenge to find input data that 
can be directly attributable to the quality 
indicators collected.
Cross-country studies of efficiency 
at the system level
Although efficiency indicators are scarce 
in international health databases, there 
are a number of studies that compare 
health care efficiency across countries. 
These studies are often cross-sectional 
and not regularly reproduced. One 
characteristic that sets these studies apart 
from the databases discussed above is 
that these studies frequently employ 
analytic frontier methods to calculate 
efficiency scores. These methodological 
approaches can address some of the issues 
that otherwise inhibit comparisons, for 
example by accounting for multiple inputs 
to health production and adjusting for 
differences in production capabilities 
at various scales. However, while many 
analytic approaches have been taken, 
there is no consensus on the “correct” 
methodological approach. Many system-
level studies have taken advantage of 
access to international harmonised 
* A curve depicting all maximum output possibilities for 
two goods, given a set of inputs consisting of resources and 
other factors. 
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datasets to compare efficiency, with their 
added value generally being the use of 
analytic techniques.
One of the first large studies to compare 
the efficiency of health systems was 
conducted by WHO to compare health 
expenditure per capita to life expectancy 
(adjusted to account for disability), after 
controlling for educational attainment  7  
for 191 countries. The models use country-
fixed effects, which take advantage of 
variations within each country over time 
to estimate parameters. An efficiency 
index was constructed, where the expected 
level of health, if there was no health care 
expenditure, is compared to the expected 
level of health if all health systems were 
as efficient as the best performer. Based 
on this analysis, only one country, Oman, 
is deemed to be efficient while Zimbabwe 
the least efficient.
The WHO efficiency study and related 
study of overall performance in the 2000 
World Health Report  3  have been heavily 
criticised both on methodological and 
data quality grounds (see Box 1). Similar 
research using DEA methods and panel 
data regression have also been carried 
out by the OECD  9  and the European 
Commission  10  as well as by independent 
authors using available international 
data. 11  Yet despite the efforts to account 
for other inputs that have an effect 
on health outcomes, such as lifestyle, 
education or institutional characteristics, 
much of the variability in efficiency 
scores appears to be unexplained by health 
system characteristics or other factors. It 
is unclear how successfully confounders 
can be controlled for. Additionally, most 
studies take a very narrow perspective on 
the outputs of the health system, with the 
main products of the health system being 
life expectancy and infant mortality. It is 
noteworthy that there seems to be little 
consistency across studies in the countries 
that are found to perform most efficiently, 
despite studies frequently relying on the 
same datasets.
Cross-country studies of efficiency 
at the sector and/or disease level
Cross-country studies also compare sub-
sectors (often hospitals) using available 
data, or utilise comparative instruments 
such as vignettes or diagnosis related 
groups (DRGs) to analyse similar patients 
and similar types of care using micro-
level data. At this less aggregated level, 
because patient characteristics are often 
more homogenous than population 
characteristics, variations in outcomes 
are likely due to unobserved confounding 
factors to a lesser degree. There are also 
a number of outputs, such as hospital 
discharges or physician visits, which can 
be assessed that are not possible at the 
health system level. Common frontier-
based analytic techniques, DEA and SFA, 
are also employed.
Studies in this area also vary in terms 
of what they compare, and which data 
they use. Some studies look at efficiency 
in hospitals, adjusting for differences in 
case severity and environmental factors. 12  
Researchers have also compared efficiency 
for specific types of care provided within 
a hospital, often using DEA models, and 
performing specific analysis amongst 
countries with similar institutional 
arrangements  13  or access to similar high 
quality patient data such as registries. 14 
Health system efficiency has also 
been explored by examining the costs, 
resources, outputs and outcomes 
associated with treating specific diseases, 
the advantage being that patients treated 
for certain diseases are likely to be more 
homogeneous. Additionally, it may be 
possible to more accurately observe the 
processes that lead to differences in 
efficiency if the data are detailed enough. 
For example, the McKinsey Health Care 
Productivity study examined variations 
in inputs and outcomes for treating breast 
cancer, lung cancer, gall stones, and 
diabetes in the US, UK and Germany. 15 
Other European projects such as the 
HealthBASKET project reviewed the costs 
of care for nine European countries. 16  
Using ‘case vignettes’ which describe 
particular types of patients (i.e. based 
on age, gender and co-morbidities), 
the study compared and attempted to 
explain variations in costs within and 
between countries. The advantage of 
this approach is that specific services 
for comparable patients could be costed 
and compared across countries. The 
more recent EuroDRG used an episode 
of care approach to compare costs 
across countries  17  based on the fact that 
most analyses of efficiency are unable 
to properly control for differences in 
case-mix. This study investigated the 
classification variables used by different 
country DRG systems, such as diagnosis, 
procedure, patient age, length-of-stay, 
death and the level of reimbursement for 
a selection of similarly defined patients 
based on episodes of care.
‘‘fewregularlyupdateddatabasescomparehealthsystemefficiency
acrosscountries
Another recent project, the European 
Health Care Outcomes, Performance and 
Efficiency project (EuroHOPE) has made 
important advances in disease-based 
efficiency comparisons across countries. 18  
This study uses linkable patient-level 
data, which allows for measurement of 
both outcomes (including follow up) and 
the use of health care resources (costs, 
days of care, procedures, and drugs) for 
comparable patient groups.
Box 1: Critiques of WHO World 
Health Report
Some critiques of the WHO study 
have illustrated that the choice of 
parametric and non-parametric 
approaches, such as Data 
Envelopment Analysis (DEA) or 
Stochastic Frontier Analysis (SFA) 
will influence the results of such an 
exercise,  3   8  as well as noting that 
such models will be sensitive to 
the assumptions made about how 
efficiency changes over time, and 
the data and methods available to 
model this.
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Key progress and remaining 
challenges
We find that while there are many 
different ways to conceptualise and 
calculate efficiency metrics, estimates 
do not generally lead to definitive 
conclusions regarding efficient health 
systems, providers or practices. Frequently 
collected metrics are simple, compare 
entire health systems, and are readily 
available in international databases, but 
because of their high level of aggregation, 
these metrics are not particularly useful for 
identifying determinants of inefficiency or 
developing appropriate policy responses. 
Advanced analytical tools are often 
used to construct more sophisticated 
system-level metrics based on data from 
these same international databases; 
however, their use of the same, limited 
datasets raises potential questions of their 
external validity.
Overall, there are few longitudinal, 
regularly updated databases that compare 
health system efficiency across countries. 
Available data is at an aggregated level, 
making it difficult to directly attribute 
output or outcome data to input data, or 
to properly adjust for confounding factors 
that might influence efficiency. Despite 
the common use of analytic methods such 
as DEA or SFA in multi-country efficiency 
studies we were not able to identify any 
regularly-updated longitudinal databases 
that employ these tools themselves in 
an effort to report efficiency scores that 
account for multiple inputs and outputs, 
or that control for factors exogenous to 
the health system. Current international 
databases are therefore limited to simple 
measures, primarily unadjusted ratios of 
outputs to inputs, to gauge cross-country 
differences in health care efficiency.
Cross-country comparisons of providers 
or sub-sectors allow for more detailed 
analysis and are a promising way forward, 
but are primarily focused on hospitals, 
with limited analysis of other types of 
care settings. Some of the most important 
gains have been made by disease-based 
efficiency studies; these studies capture 
variations in the costs, processes, and 
outcomes associated with treating 
particular diseases, and can often be 
linked to registry data containing non-
health based characteristics (e.g. income, 
education, occupation). Longitudinal 
disease-based studies that take advantage 
of high quality patient-level data allow 
numerous observable non-health-
related confounders to be controlled 
for when comparing the treatment of 
specific diseases across countries, 
providing important insight into health 
production processes.
Conclusions
While there has been considerable 
progress, much work remains before 
internationally comparable efficiency 
metrics should play a formal role in 
informing health policy. To ensure that 
international health system efficiency 
metrics do not misinform policy decisions, 
it is essential for continued efforts 
to enhance data quality, availability 
and comparability.
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